Cited by — Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trial | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trial.
No admitted local citation edges point to this work yet.
